Transfusion-dependent thalassaemia: a new era.
Berdoukas
Vasili
V
Modell
Bernadette
B
D001565:Benzoates / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000209:etiology / Q000401:mortality; D000077588:Deferasirox; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D017707:Erythrocyte Transfusion; D005293:Ferritins / Q000378:metabolism; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D010349:Patient Compliance; D011728:Pyridones / Q000627:therapeutic use; D017262:Siderophores / Q000627:therapeutic use; D013789:Thalassemia / Q000453:epidemiology / Q000628:therapy*; D014230:Triazoles / Q000627:therapeutic use
D001565:Benzoates; D007502:Iron Chelating Agents; D011728:Pyridones; D017262:Siderophores; D014230:Triazoles; D000077543:Deferiprone; D005293:Ferritins; D003676:Deferoxamine; D000077588:Deferasirox